American Journal of Clinical Dermatology

, Volume 14, Issue 2, pp 111–123

Infantile Hemangiomas

An Update
  • Eun-Kyung Mary Kwon
  • Marcia Seefeldt
  • Beth A. Drolet
Review Article

DOI: 10.1007/s40257-013-0008-x

Cite this article as:
Kwon, EK.M., Seefeldt, M. & Drolet, B.A. Am J Clin Dermatol (2013) 14: 111. doi:10.1007/s40257-013-0008-x

Abstract

Infantile hemangioma (IH) is a common vascular tumor of infancy. Although benign, infants with IH can experience complications including ulceration, visual and airway impairment, and residual scarring and disfigurement. It is often challenging for clinicians to predict which tumors are in need of systemic treatment. However, data from various demographic and other studies have revealed further insights into this tumor. This article reviews the identification, evaluation, and management of high-risk IHs, including the indications for treatment and the use of systemic treatments such as corticosteroids, β-blockers, and vincristine.

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  • Eun-Kyung Mary Kwon
    • 1
  • Marcia Seefeldt
    • 2
  • Beth A. Drolet
    • 2
  1. 1.Department of DermatologyMedical College of WisconsinMilwaukeeUSA
  2. 2.Department of Dermatology and PediatricsMedical College of WisconsinMilwaukeeUSA